Peptide therapy for fitness: hype vs. what studies show

What did @alisonjoanneortiz actually say?

The creator says she's three weeks into a sermorelin protocol and noticed something she didn't expect: her anxiety and depression symptoms have eased. She describes feeling "very clear, very level headed" and credits this to sermorelin's effect on growth hormone. She also read that "low levels of growth hormone can actually contribute to feelings of depression and anxiety" and concluded that raising GH through sermorelin explains her mood lift. She reports better gym recovery, less soreness, and the ability to lift heavier, but notes no body composition changes yet. She frames this as an anecdotal share while also making a fairly direct recommendation: "definitely recommend Samoralin so far for me."

She's transparent about limitations. She hasn't finished researching sermorelin's effects on the menstrual cycle, she acknowledges the mental health piece is personal, and she's not claiming a cure. That intellectual honesty is worth noting. But the leap from "I feel better" to "sermorelin is fantastic for women" for mental health is one the evidence doesn't fully support yet.

Does the science back this up?

There is real research connecting growth hormone deficiency to mood disorders, but the picture is messier than the video implies. Growth hormone deficiency in adults is associated with depressive symptoms, reduced energy, and impaired quality of life. Treating confirmed GH deficiency with recombinant human growth hormone has shown mood improvements in some studies. But that's a different population than a fitness instructor using a growth hormone-releasing hormone analog without a documented deficiency.

Sermorelin stimulates the pituitary to release GH naturally, which is a more physiologically conservative approach than direct GH administration. A 2019 review by Sigalos and Pastuszak in Current Urology Reports notes that GHRH analogs like sermorelin can raise IGF-1 levels and improve some quality-of-life markers, but the evidence base for mental health outcomes specifically is thin. A 2000 study by Burman et al. in Clinical Endocrinology found mood and well-being improvements in GH-deficient adults on GH therapy, but extrapolating that to healthy individuals using a secretagogue is speculative. The creator's reported mood benefits are plausible but not proven by the mechanism she describes.

What did they get wrong (or right)?

She got the basic biology directionally correct. GH does interact with mood-regulating systems. GH receptors exist in the brain, and IGF-1 has been studied for antidepressant effects in animal models. A 2013 paper by Duman and Bhagya in Neuropharmacology showed IGF-1 signaling plays a role in neuroplasticity, which is relevant to mood. So the underlying logic isn't invented.

What she got wrong, or at least overstated, is the certainty. Saying sermorelin is "fantastic for women" for mental health based on three weeks of personal experience and some online reading isn't a conclusion the evidence supports. She's describing a confound-heavy situation: she could be feeling better due to improved sleep quality, the gym benefits she mentions, a placebo response, or natural mood variation. Three weeks is also not enough time to separate signal from noise for a compound with gradual onset effects.

• The GH-mood link exists in deficient populations. Applying it to healthy adults is a stretch.
• Her gym recovery improvements are more consistent with the existing literature on sermorelin in recreational athletes.
• She was right to flag uncertainty about cycle effects. There's almost no published data on sermorelin and menstrual cycle changes.

What should you actually know?

Sermorelin is an FDA-approved peptide (for pediatric GH deficiency) that's widely used off-label in adults for anti-aging, body composition, and recovery purposes. It's generally considered safer than exogenous GH because it works through your own pituitary, with natural feedback loops intact. But off-label use in healthy adults without a confirmed GH deficiency sits in a gray zone where benefits are often reported anecdotally and long-term safety data is limited.

If you're considering sermorelin for mental health specifically, that framing should involve a clinician who can assess whether you have actual GH axis dysfunction, not just a TikTok recommendation. For recovery and sleep, the evidence is more supportive. A 2019 paper by Sigalos and Pastuszak noted improvements in sleep quality and body composition in some adult cohorts. The mental health angle needs more rigorous study before it should be a selling point.

• Sermorelin is not a treatment for anxiety or depression. Period.
• Mood improvements on sermorelin could be real, but attributing them specifically to GH elevation requires more than three weeks and a PubMed scroll.
• Anyone experiencing clinically significant anxiety or depression should work with a mental health professional, not self-experiment with peptides.